NYSE: PENPenumbra Inc Stock Ownership - Who owns Penumbra?
Insider buying vs selling
Have Penumbra Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Shruthi Narayan | President | 2026-01-15 | 286 | $350.49 | $100.24kSell |
| Harpreet Grewal | Director | 2026-01-06 | 186 | $312.64 | $58.15kSell |
| Thomas Wilder | Director | 2026-01-02 | 186 | $310.72 | $57.79kSell |
| Johanna Roberts | EVP Gen. Counsel Secretary | 2025-12-15 | 1,130 | $309.15 | $349.34kSell |
| Lambert Shiu | Chief Accounting Officer | 2025-12-15 | 300 | $309.15 | $92.75kSell |
| Maggie Yuen | Chief Financial Officer | 2025-12-15 | 565 | $309.15 | $174.67kSell |
| Arani Bose | Director | 2025-12-11 | 520 | $307.10 | $159.69kSell |
| Arani Bose | Director | 2025-12-11 | 2,082 | $310.50 | $646.46kSell |
| Arani Bose | Director | 2025-12-11 | 3,523 | $311.47 | $1.10MSell |
| Arani Bose | Director | 2025-12-11 | 2,030 | $305.19 | $619.54kSell |
PEN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PEN insiders and whales buy or sell their stock.
PEN Shareholders
What type of owners hold Penumbra Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Fmr LLC | 15.04% | 5,891,665 | $2.11B | Institution |
| Blackrock Inc | 10.65% | 4,170,892 | $1.49B | Institution |
| Vanguard Group Inc | 9.79% | 3,835,483 | $1.37B | Institution |
| Price T Rowe Associates Inc | 4.58% | 1,794,267 | $642.65M | Institution |
| Walter Charles Wang | 3.79% | 1,484,931 | $531.86M | Insider |
| State Street Corp | 2.97% | 1,164,950 | $417.25M | Institution |
| Citadel Advisors LLC | 2.48% | 970,998 | $347.78M | Institution |
| Baillie Gifford Co | 2.32% | 908,546 | $325.41M | Institution |
| Rtw Investments LP | 2.21% | 866,499 | $310.35M | Institution |
| Jpmorgan Chase Co | 2.15% | 843,697 | $302.19M | Institution |
PEN vs Medical Device Stocks
Penumbra Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.